CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-05 | Krishnan Krish S President and CEO | Sale | −8,992 | $80.22 | $721K | 1,743,271 |
| 2022-08-05 | Krishnan Krish S President and CEO | Sale | −13,432 | $81.62 | $1.1M | 1,729,839 |
| 2022-08-05 | Krishnan Krish S President and CEO | Sale | −2,576 | $82.20 | $212K | 1,727,263 |
| 2022-06-30 | Sutherland Everett Rand Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2022-06-30 | ROSSI DINO A Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2022-06-30 | JANNEY DANIEL Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2022-06-30 | Mason Christopher Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2022-06-30 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2022-02-28 | ORTH ANDREW C. Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-02-28 | Romano Kathryn Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-02-28 | Krishnan Suma President, R&D | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-02-28 | Krishnan Krish S President and CEO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-02-26 | Romano Kathryn Chief Accounting Officer | Shares withheld for taxes | −1,472 | $62.50 | $92K | 18,128 |
| 2022-02-26 | Krishnan Suma President, R&D | Shares withheld for taxes | −3,282 | $62.50 | $205K | 1,752,263 |
| 2022-02-26 | Krishnan Krish S President and CEO | Shares withheld for taxes | −4,655 | $62.50 | $291K | 1,813,688 |
| 2022-01-31 | Sutherland Everett Rand Director | Grant or award · Stock Option (Right to Buy) | +13,600 | 13,600 | ||
| 2022-01-31 | Marantz Jing L. Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +205,000 | 205,000 | ||
| 2021-12-10 | Krishnan Suma Chief Operating Officer | Sale | −100,000 | $70.50 | $7.0M | 50,000 |
| 2021-12-10 | JANNEY DANIEL Director | Sale | −100,000 | $70.50 | $7.0M | 266,362 |
| 2021-12-10 | Krishnan Krish S President and CEO | Sale | −100,000 | $70.50 | $7.0M | 50,000 |
Page 36 of 42 · 828 trades